Depo Provera Lawsuit
Depo Provera faces legal scrutiny as cases arise linking the birth control drug to increased brain tumor risks. You may be entitled to compensation, if you have developed Cerebral Meningioma (Malignant or Benign).
During the March Case Management Conference, Judge Rodgers ordered generic drug defendants Greenstone, Viatris, and Prasco to submit affidavits affirming their non-involvement with the drug at issue. Case Management Order No. 2 required submission within 14 days, along with a Notice of Compliance. While Prasco met the deadline, Greenstone and Viatris did not, prompting the court to issue an Order to Show Cause. In a subsequent order, the court confirmed that both Greenstone and Viatris have now submitted the required affidavits. Judge Rodgers emphasized her expectation of strict adherence to deadlines and made clear that noncompliance will be met with judicial scrutiny
Plaintiffs must complete a “Plaintiff Proof of Use/Injury Questionnaire” within 120 days of March 14, 2025, or within 120 days of filing. To support this, a court order compels third parties—including pharmacies, clinics, insurers, and military providers—to produce records showing Depo-Provera or generic DMPA injections, even where traditional medical records are missing. The order permits use of a court-approved HIPAA and HITECH-compliant release and provider identification form. If providers do not cooperate, counsel may issue subpoenas without additional steps. Facilities must comply and cannot impose separate forms, original signature requirements, or unreasonable fees that delay production.
Judge Rodgers is advancing the Depo Provera MDL swiftly. Since its consolidation on February 7, the Court has issued multiple pretrial orders and structured a clear discovery roadmap. BrownGreer has been appointed Data Administrator, Judge Herndon as Special Master, and a Common Benefit Special Master to oversee fees. Key agreements on direct filing, service, confidentiality, and discovery protocols are in place. The parties must propose a process for handling plaintiff submission deficiencies by April 14. Discovery is progressing rapidly, with preemption defenses set for resolution by late July and expert discovery concluding in early 2026, keeping the litigation on track.
A new court order allows women to file Depo-Provera brain tumor lawsuits directly in the MDL, eliminating the need for case transfers from other federal courts. This ruling streamlines the process and avoids delays. Judge Rodgers also ruled that no master or short-form complaints are required, removing additional procedural steps. The decision accelerates litigation and enables new cases to be filed directly in the Northern District of Florida, regardless of where plaintiffs were diagnosed. This change makes it easier for affected women to pursue claims without procedural barriers.
Depo Provera was once a popular birth control choice for women seeking long-term contraception without the inconvenience of taking daily pills. However, disturbing claims have recently started to surface that the birth control injections can lead to the development of brain tumors.
As more women face the diagnosis of brain tumors after using Depo Provera, many are coming forward, claiming that they were never told about the risks associated with the drug.
Depo Provera (depot medroxyprogesterone acetate), manufactured by Pfizer, is an injectable form of birth control that relies on progestin. It works by slowly releasing the hormone to prevent ovulation for 12 to 14 weeks between injections.
Often referred to as the “Depo Shot”, the injection is administered by a healthcare professional into the muscles of the arm or buttocks. Many women relied on this convenient option, trusting that it was safe for long-term use.
The problem lies in the alleged connection between Depo Provera and meningiomas, which are tumors that form on the brain and spinal cord. Recent studies have suggested a link between prolonged use of Depo Provera and an increased risk of developing brain tumors.
Despite these potential dangers, Pfizer is accused of failing to warn the women using the birth control method of the possible risks. Women who took Depo Provera for extended periods may have unknowingly exposed themselves to these risks. Many are now facing serious health consequences.
The primary concern associated with Depo Provera is its link to meningioma tumors. Although meningioma brain tumors are often benign, they can still cause significant health problems due to their location.
In many cases, meningioma tumors may require surgery. They can also lead to other complications like headaches, vision problems, or even seizures.
Women who took Depo Provera for years are now dealing with these life-altering conditions, and they’re looking for answers.
Around the world, millions of women have used Depo Provera and generic versions to prevent pregnancy since approval in 1992 by the U.S. Food and Drug Administration (FDA).
A study released in March 2024 and carried out by the British Medical Journal (BMJ) found that women who used Depo Provera were 5.6 times more likely to develop a brain tumor.
Reports show that the risks associated with Depo Provera and the development of brain tumors have been submitted to the FDA for decades. The data also shows that incidences of brain tumors are continuing to increase. Despite the reports, Pfizer failed to warn women about the potential risks.
The main claims in the Depo Provera lawsuits include:
To pre-qualify, you must have used Depo-Provera, Depo-SubQ Provera, or an authorized generic form of medroxyprogesterone acetate at least twice after 1992.
You must have also been diagnosed with meningioma or a brain tumor at least 2 years after your first shot.
Factors like the length of Depo-Provera use, the time between the last use and your diagnosis, as well as the type of brain tumor or meningioma diagnosed, will also be considered. You will need to speak to a lawyer about the specifics of your case.
As more women learn about the possible dangers of Depo Provera, lawsuits are being submitted across the country. Many of these lawsuits claim that Pfizer failed to adequately warn women about the risks of developing meningiomas.
Women who used Depo Provera are seeking compensation for medical expenses, lost wages, pain and suffering, and other damages related to their diagnoses. The goal of the plaintiffs is to hold Pfizer accountable for the harm caused by their product.
If you took Depo Provera and later developed a brain tumor, you may be eligible to join a class action lawsuit.
Your first step should be to consult with your doctor to discuss your use of Depo Provera and determine if your health problems are linked to the use of injectable birth control.
If you’ve been diagnosed with a brain tumor, you may be able to pursue financial compensation. First, you’ll want to gather your medical records, including documentation of your Depo Provera use and your diagnosis.
If you or a loved one has been affected by Depo Provera, now is the time to take action. Thousands of women are seeking justice for the harm they’ve suffered, and you may be entitled to compensation.
Joining a class action lawsuit is about more than obtaining a settlement. It’s also about holding Pfizer accountable for the safety of the products they sell.
The potential dangers of Depo Provera have left many women feeling betrayed and uncertain about their future and health.
If you’ve taken Depo Provera and are now facing health issues, you’re not alone. Class action lawsuits offer a way to seek justice and compensation for the suffering and associated risks of using Depo Provera.
Don’t wait. Consult with your doctor, explore your legal options, and take steps to protect your rights. We encourage you to start the process of finding out if you may qualify for a Depo Provera class action lawsuit. We can help you stay informed and provide you with the latest updates regarding the lawsuit. Subscribe to OnlyClassActions for further details.
This is an advertisement. OnlyClassActions is not a law firm or referral service, and we do not provide legal advice. OnlyClassActions provides a free service for individuals seeking legal representation, and we do not charge you to be connected with an attorney. We do not recommend or endorse any attorneys that pay to participate. OnlyClassActions utilizes a pool of attorneys in each jurisdiction, and attorneys are selected through a round-robin process without our evaluating your legal situation when selecting which attorney will receive your information. OnlyClassActions makes no representation about the quality of legal services or the qualifications of any attorney participating in our pool. Information you submit will be shared with third-party attorney(s). An attorney-client relationship is not formed when you submit information through the form. Hiring a lawyer is a critical decision and should not be predicated solely on comments, advertisements, or other content found on any website. You are under no obligation to retain a lawyer who contacts you through this service.
Join our newsletter to stay up to date on cases and settlements.
Please enter your email address below
Thanks for signing up. We'll send you className action news, updates and trending lawsuits to keep you up-to-date.
May 13, 2024 /
14
2
50
May 13, 2024 /
25
0
30
June 07, 2024 /
9
0
6
May 13, 2024 /
12
0
3
Add Comment